Variables

DM (n: 96)

Non-DM (n: 156)

P-value

Clinical data

Age (years)

60.1 (±9.3)

55.1 (±11.6)

0.009

Male, n (%)

68 (70.8)

102 (66.2)

0.592

Smoking, n (%)

24 (25)

64 (41.6)

0.059

Hypertension, n (%)

42 (43.8)

52 (33.8)

0.262

Hyperlipidemia, n (%)

22 (22.9)

36 (23.4)

0.953

Stable angina, n (%)

56 (58.3)

56 (36.4)

0.016

Unstable angina, n (%)

16 (16.7)

16 (10.4)

0.307

STEMI, n (%)

20 (20.8)

66 (42.9)

0.012

NSTEMI, n (%)

4 (4.2)

16 (10.4)

0.364

Left ventricular systolic EF %

EF > 55

40 (41.7)

96 (62.3)

0.015

EF 55 - 50

18 (18.8)

32 (20.8)

EF < 50

38 (39.6)

26 (16.9)

ECG change, n (%)

36 (37.5)

122 (79.2)

0.041

Site of lesions and characters

LM lesion, n (%)

10 (10.4)

4 (2.6)

0.012

LAD lesion, n (%)

88 (91.7)

102 (66.2)

0.001

LCX lesion, n (%)

52 (54.2)

54 (35.1)

0.036

RCA lesion, n (%)

72 (75.0)

78 (50.6)

0.007

RCA dominant, n (%)

80 (83.3)

104 (67.5)

0.075

LCX dominant, n (%)

12 (12.5)

24 (15.6)

Codominant, n (%)

4 (4.2)

26 (16.9)

Ectasia, n (%)

10 (10.4)

6 (3.9)

0.283

Tortuosity, n (%)

10 (10.4)

16 (10.4)

1.000

Atherosclerotic coronary arteries n (%)

88 (91.7)

114 (74.0)

0.015

Normal, n (%)

8 (8.3)

48 (31.2)

0.001

Single vessel, n (%)

8 (8.3)

44 (28.6)

Two-vessels, n (%)

32 (33.3)

32 (20.8)

Three-vessels, n (%)

48 (50)

30 (19.5)

Type A, n (%)

17 (17.7)

75 (48.7)

0.010

Type B, n (%)

66 (68.8)

58 (37.7)

Type C, n (%)

70 (72.9)

60 (39)

Non-significant, n (%)

3 (3.1)

25 (16.2)

0.032

Significant, n (%)

43 (44.8)

51 (33.1)

Total occlusion, n (%)

42 (43.8)

30 (19.5)